04/24/2024
8:55 PM | FibroGen (Filer)
| Form ARS | |
04/24/2024
4:01 PM | FibroGen (Filer)
| Form DEF 14A | |
04/24/2024
4:08 PM | FibroGen (Filer)
| Form DEFA14A | |
04/24/2024
3:15 PM | Adib Deyaa (Reporting)
FibroGen (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2024
4:58 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
6:06 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
6:18 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:19 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:33 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:28 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:29 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
2:37 PM | ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
| Form SC 13G | |
02/05/2024
7:08 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:28 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:19 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:20 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
3:21 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:05 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:11 PM | FibroGen (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:30 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
6:41 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
6:37 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:54 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
7:55 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2023
6:37 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
6:38 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
4:31 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2023
4:14 PM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
4:28 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
6:10 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
3:42 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2023
7:32 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:47 PM | FibroGen (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
07/19/2023
6:01 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
7:28 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2023
3:46 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
6:36 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:27 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
8:05 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/23/2023
8:53 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/22/2023
5:32 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4/A | |
06/15/2023
7:17 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
5:15 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
6:52 PM | FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:53 PM | FibroGen (Issuer)
Lema Gerald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | FibroGen (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:54 PM | Blaug Suzanne (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:55 PM | Brennan Aoife (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:56 PM | Cravatt Benjamin (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:10 PM | Cravatt Benjamin (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:11 PM | EDWARDS JEFFREY L (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:14 PM | Blaug Suzanne (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:17 PM | Brennan Aoife (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
6:51 PM | FibroGen (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:38 PM | Chung Christine (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Graham Juan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:39 PM | FibroGen (Issuer)
Wettig Thane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:10 PM | Conterno Enrique A (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
6:12 PM | Eisner Mark (Reporting)
FibroGen (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:49 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:51 PM | FibroGen (Subject)
Ho Maykin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:51 PM | FibroGen (Subject)
Henderson Jeffrey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:51 PM | FibroGen (Subject)
Graham Juan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:31 PM | Chung Christine (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:36 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:41 PM | FibroGen (Subject)
Wettig Thane (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
9:34 AM | FibroGen (Subject)
Schoeneck James A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:00 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:53 PM | Eisner Mark (Reporting)
FibroGen (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2023
8:00 AM | FibroGen (Filer)
| Form DEFA14A | |
05/18/2023
6:35 AM | FibroGen (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
